Aquarius Surgical Technologies Inc.
AQQRF · OTC
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Market Cap | $167 | $157 | $672 | $170 |
| - Cash | $8 | $107 | $122 | $158 |
| + Debt | $6,470 | $4,042 | $3,510 | $779 |
| Enterprise Value | $6,629 | $4,091 | $4,060 | $791 |
| Revenue | $91 | $205 | $204 | $328 |
| % Growth | -55.6% | 0.7% | -37.8% | – |
| Gross Profit | $47 | $133 | $74 | $79 |
| % Margin | 51.9% | 64.7% | 36.4% | 24.2% |
| EBITDA | -$833 | -$430 | -$517 | -$636 |
| % Margin | -913.1% | -209.4% | -253.9% | -194.2% |
| Net Income | -$1,167 | -$758 | -$723 | -$859 |
| % Margin | -1,279.8% | -369.1% | -355.1% | -262.2% |
| EPS Diluted | -0.04 | -0.028 | -0.029 | -0.037 |
| % Growth | -45.5% | 5.5% | 21.8% | – |
| Operating Cash Flow | -$383 | -$253 | $53 | -$133 |
| Capital Expenditures | $0 | -$4 | $0 | -$5 |
| Free Cash Flow | -$383 | -$257 | $53 | -$138 |